CELG News 86.19 07/25/2014 04:48:33 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 86.19 $CELG

Why Celgene Stock Was Down 3% Today
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Thu Jul 24, 6:05PM CDT
Celgene  turned in a quarter that beat analyst expectations on the top and bottom lines, with revenue up 17% year-over-year and adjusted EPS up 18% year-over-year, yet the market didn't appear too impressed (the stock sold off about 3% today). In...

Final Glance: Biotechnology companies
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Shares of CELG Up 16.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 24, 4:50PM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 3 months, Celgene has returned 16.58% as of today's recent price of $86.19.

Celgene, Alexion Beat Estimates, But Biotechs Fall
at Investor's Business Daily - Thu Jul 24, 4:07PM CDT
Big-cap biotechs Celgene and Alexion Pharmaceuticals modestly beat Q2 estimates and raised their guidance early Thursday, but their shares tumbled as Wall Street seemed to turn against the sector. Celgene's (CELG) Q2 earnings rose 18% over the...

Celgene Stock Earnings: Key Takeaways
Todd Campbell, The Motley Fool - Motley Fool - Thu Jul 24, 4:03PM CDT
Celgene   is one of biotechnology's brightest shining stars. The company markets a slate of therapies, including its mega blockbuster multiple myeloma drug Revlimid, its fast-growing cancer drug Abraxane, and its newly launched autoimmune drug,...

Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 12:48PM CDT
The rise in healthcare spending, if true, will increase business for hospitals, diagnostic centers and healthcare related industry. Eventually, the healthcare industry should benefit and help healthcare funds be better investment potential.

Midday Glance: Biotechnology companies
AP - Thu Jul 24, 12:23PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Video: Celgene, Alexion Earnings Top, But Stocks Fall
at Investor's Business Daily - Thu Jul 24, 10:39AM CDT
Big-cap biotechs Celgene (CELG) and Alexion Pharmaceuticals (ALXN) both modestly beat Q2 estimates and raised their guidance Thursday morning, but their shares were falling in the stock market today as Wall Street seemed to hope for more. Celgene's...

Early Glance: Biotechnology companies
AP - Thu Jul 24, 10:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Jim Cramer's Stop Trading: Consider Buying Celgene on Friday
at The Street - Thu Jul 24, 10:10AM CDT
TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, reasoned that investors should buy the weakness in Celgene.

Stocks Up And Down At Open; Under Armour, Facebook Surge
at Investor's Business Daily - Thu Jul 24, 9:31AM CDT
Stocks opened in a narrowly mixed stance Thursday. The Dow Jones industrial average and the S&P 500 inched up a fraction each. The Nasdaq dipped 0.1% as Qualcomm (QCOM), Celgene (CELG) and Alexion Pharmaceuticals (ALXN) dived after delivering...

Celgene's Narrow Beat on Second-Quarter Earnings Fails to Impress Investors; Shares Fall
George Budwell, The Motley Fool - Motley Fool - Thu Jul 24, 9:23AM CDT
Celgene Corporation reported second-quarter earnings  before the bell today, posting an adjusted diluted EPS of $0.90 on a split-adjusted basis, narrowly beating the Street's expectations by $0.01. The company generated $1.873 billion in revenue...

Stock Market News for July 24, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 9:10AM CDT
Benchmarks finished mostly higher on Wednesday following upbeat quarterly results from healthcare and technology companies

Celgene (CELG) Stock Falls After Mixed Second-Quarter Earnings
at The Street - Thu Jul 24, 8:16AM CDT
Celgene (CELG) dipped 2.21% to $87.15 in pre-market trading on Thursday after the biotechnology company reported mixed second-quarter results.

Today's Top Health Care Stocks: Alexion Pharmaceuticals, Bristol-Myers Squibb, Celgene Corp. and Eli
George Budwell, The Motley Fool - Motley Fool - Thu Jul 24, 7:46AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Alexion Pharmaceuticals , Bristol-Myers Squibb , Celgene Corporation and  Eli Lilly .  Alexion tops consensus for the second quarter Alexion beat...

Celgene Reports Second Quarter 2014 Operating and Financial Results
Business Wire - Thu Jul 24, 6:31AM CDT
--- Data on GED-0301, MDS-005 and MCL-002 to be Presented H2 2014

Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG
at The Street - Thu Jul 24, 5:00AM CDT
Cramer says Chipotle is a huge winner while his 'four horsemen' of Celgine, Gilead Sciences, Regeneron and Biogen Idec are pulling away from the biotech pack.

Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom
at The Street - Wed Jul 23, 7:05PM CDT
Should investors settle for average results? Absolutely not, Cramer says.

Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 3:34PM CDT
Eli Lilly and Company (LLY) is set to report second-quarter 2014 results on Jul 24.

Earnings Preview: Bristol-Myers Squibb and Celgene Corporation
George Budwell, The Motley Fool - Motley Fool - Wed Jul 23, 1:00PM CDT
Most health care stocks have been experiencing a roller coaster ride so far this year. While the underlying cause(s) of this volatility is likely multifaceted in nature, I think a fair amount is attributable to the uncertain outlook regarding some of...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 167

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 112

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 86

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 100

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 86

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 30

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 101

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 62

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 125

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Experiences Coming to Myrtle Beach in 2025

Updated Category News Views 1799

Discover What's New and Exciting in Myrtle Beach Fresh, unique adventures await at The Beach. As one of the Southeast's most beloved travel destinations, Myrtle Beach is gearing up for an exciting new year filled with unforgettable new and expanded experiences, alongside its iconic offerings that continue to draw visitors to its golden shores from across the nation. With...

Continue Reading
NXP Semiconductors Showcases Strong Energy and Growth Initiatives

Updated Category News Views 250

NXP Semiconductors Posts Impressive Q3 2025 Financial Results NXP Semiconductors N.V. (NASDAQ: NXPI) has announced its financial results for the third quarter, revealing a revenue of $3.17 billion. This performance exceeded market expectations and places NXP in a strong position amidst improving economic conditions. The company's president, Rafael Sotomayor, highlighted...

Continue Reading
Red Pine Exploration Secures Significant Funding Through Placement

Updated Category News Views 81

Red Pine Exploration Announces Major Funding Initiative Today, Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) has captured attention with its announcement of a significant C$7.0 million private placement. This deal, arranged by Haywood Securities Inc. and Research Capital Corporation, sets the stage for the company’s growth while bolstering its gold exploration...

Continue Reading
Ken Griffin Critiques Trump's Tariff Policies Impacting Economy

Updated Category News Views 172

Ken Griffin's Strong Critique of Tariff Policies Ken Griffin, known as the CEO of Citadel LLC, has emerged as a vocal critic of former President Donald Trump's tariff policy, labeling it as detrimental to the American economy. Griffin's stance marks a significant shift from his previous support for Trump, and he is urging for a reevaluation of the existing economic...

Continue Reading
Investigation Launched into Spyre Therapeutics by Pomerantz

Updated Category News Views 175

Pomerantz LLP Investigates Spyre Therapeutics, Inc. Pomerantz LLP is currently conducting an investigation on behalf of investors in Spyre Therapeutics, Inc. (NASDAQ: SYRE). This investigation seeks to uncover whether the company, along with its officials and directors, has engaged in fraudulent activities or other illicit business practices. Investors who believe they...

Continue Reading